ruxreprints / RuxReprints

Robots.txt Information

Robot	Path	Permission
GoogleBot	/	✔
BingBot	/	✔
BaiduSpider	/	✔
YandexBot	/	✔
User-Agent: * Allow: / Disallow: /config* Disallow: /404* Disallow: /500* Sitemap:

Meta Tags

Title	RuxReprints
Description	RuxReprints.com Access to clinical study articles Choose a disease state below and select an article for more information. Main navigation --> Polycyth
Keywords	N/A

Server Information

WebSite	ruxreprints.com
Host IP	34.196.241.156
Location	United States

Related Websites

                        Site
                        Rank
                    

More to Explore

ruxreprints.com Valuation

US$258,770

Last updated: 2023-05-17 10:31:06

ruxreprints.com has Semrush global rank of 40,902,411. ruxreprints.com has an estimated worth of US$ 258,770, based on its estimated Ads revenue. ruxreprints.com receives approximately 29,859 unique visitors each day. Its web server is located in United States, with IP address 34.196.241.156. According to SiteAdvisor, ruxreprints.com is safe to visit.

Traffic & Worth Estimates

Purchase/Sale Value	US$258,770
Daily Ads Revenue	US$239
Monthly Ads Revenue	US$7,166
Yearly Ads Revenue	US$85,992
Daily Unique Visitors	1,991
Note: All traffic and earnings values are estimates.

DNS Records

Host	Type	TTL	Data
ruxreprints.com.	A	14400	IP: 34.196.241.156
ruxreprints.com.	NS	14400	NS Record: dns1.cscdns.net.
ruxreprints.com.	NS	14400	NS Record: dns2.cscdns.net.
ruxreprints.com.	MX	14400	MX Record: 10 custmx.cscdns.net.
ruxreprints.com.	TXT	14400	TXT Record: ruxreprints-prod.azurewebsites.net

HtmlToTextCheckTime:2023-05-17 10:31:06

RuxReprints.com Access to clinical study articles Choose a disease state below and select an article for more information. Main navigation --> Polycythemia vera Myelofibrosis Acute graft-versus-host disease RESPONSE study: Ruxolitinib vs best available therapy Long-term efficacy and safety of ruxolitinib versus best available therapy in polycythaemia vera (RESPONSE): 5-year follow up of a phase 3 study LEARN MORE Kiladjian JJ, Zachee P, Hino M, et al. Lancet Haematol. 2020 Mar;7(3):e226-e237. Ruxolitinib versus standard therapy for the treatment of polycythemia vera LEARN MORE Vannucchi AM, Kiladjian JJ, Griesshammer M, et al. N Engl J Med. 2015;372(5):426-435. RESPONSE-2 study: Jakafi vs best available therapy Ruxolitinib for the treatment of inadequately controlled polycythaemia vera without splenomegaly (RESPONSE-2): a randomised, open-label, phase 3b study LEARN MORE Passamonti F, Griesshammer M, Palandri F, et al. Lancet Oncol. 2017;18(1):88-99. RELIEF study: Jakafi vs

HTTP Headers

HTTP/1.1 301 Moved Permanently
Server: nginx
Date: Fri, 11 Mar 2022 00:45:41 GMT
Content-Type: text/html; charset=iso-8859-1
Content-Length: 236
X-Content-Type-Options: nosniff
Location: https://www.ruxreprints.com/
Cache-Control: max-age=1209600
Expires: Fri, 25 Mar 2022 00:45:41 GMT
X-Request-ID: v-9410f2b4-a0d4-11ec-9d9c-ab4913d25f75
Age: 891132
Via: varnish
X-Cache: HIT
X-Cache-Hits: 97
Connection: keep-alive

HTTP/2 200 
server: nginx
date: Mon, 21 Mar 2022 08:17:54 GMT
content-type: text/html; charset=UTF-8
content-length: 42411
cache-control: max-age=86400, public
x-drupal-dynamic-cache: MISS
link: ; rel="canonical", ; rel="shortlink"
link: ; rel="alternate"; hreflang="en-us"
link: ; rel="revision"
x-ua-compatible: IE=edge
content-language: en
x-content-type-options: nosniff
x-frame-options: SAMEORIGIN
expires: Sun, 19 Nov 1978 05:00:00 GMT
last-modified: Sun, 20 Mar 2022 09:38:36 GMT
vary: Cookie,Accept-Encoding
x-generator: Drupal 8 (https://www.drupal.org)
content-security-policy: report-uri /report-csp-violation
x-content-security-policy: report-uri /report-csp-violation
x-webkit-csp: report-uri /report-csp-violation
x-xss-protection: 1
strict-transport-security: max-age=2592000; includeSubDomains; preload
from-origin: same
referrer-policy: same-origin
expect-ct: max-age=86400, enforce
feature-policy: camera 'none'; fullscreen 'self'; geolocation *; microphone 'none' https://www.ruxreprints.com/*
x-drupal-cache: MISS
x-request-id: v-84658aa0-a831-11ec-8453-7f0dfec94104
x-ah-environment: 01live
age: 81557
etag: W/"1647769116"
via: varnish
x-cache: HIT
x-cache-hits: 22
accept-ranges: bytes

ruxreprints.com Whois Information

Domain Name: RUXREPRINTS.COM
Registry Domain ID: 2018820274_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.corporatedomains.com
Registrar URL: http://cscdbs.com
Updated Date: 2021-03-31T05:19:31Z
Creation Date: 2016-04-04T15:13:12Z
Registry Expiry Date: 2022-04-04T15:13:12Z
Registrar: CSC Corporate Domains, Inc.
Registrar IANA ID: 299
Registrar Abuse Contact Email: domainabuse@cscglobal.com
Registrar Abuse Contact Phone: 8887802723
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: DNS1.CSCDNS.NET
Name Server: DNS2.CSCDNS.NET
DNSSEC: unsigned
>>> Last update of whois database: 2022-03-21T09:00:26Z <<<

ruxreprints.com valuation and analysis